|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
0.01/0.56
|
企業價值
--
|
資產負債 |
每股賬面淨值
3.95
|
現金流量 |
現金流量率
--
|
損益表 |
收益
--
|
每股收益
--
|
同行比較
|
||||||||||||||||
|
報價延遲最少15分鐘:2024/05/04 04:51 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions. |